BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 1704999)

  • 1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
    Johnston PG; Drake JC; Trepel J; Allegra CJ
    Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR.
    Shibata J; Aiba K; Shibata H; Minowa S; Horikoshi N
    Anticancer Res; 1998; 18(3A):1457-63. PubMed ID: 9673356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
    Chu E; Koeller DM; Johnston PG; Zinn S; Allegra CJ
    Mol Pharmacol; 1993 Apr; 43(4):527-33. PubMed ID: 8474431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E; Zinn S; Boarman D; Allegra CJ
    Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.
    Copur S; Aiba K; Drake JC; Allegra CJ; Chu E
    Biochem Pharmacol; 1995 May; 49(10):1419-26. PubMed ID: 7763285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
    Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
    Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
    Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
    McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
    Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA.
    Chu E; Lai GM; Zinn S; Allegra CJ
    Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
    Wang W; Marsh S; Cassidy J; McLeod HL
    Cancer Res; 2001 Jul; 61(14):5505-10. PubMed ID: 11454699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
    Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
    Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of thymidylate synthase mRNA in 5-fluorouracil resistant human colon adenocarcinoma cells].
    Shibata J; Aiba K; Shibata H; Minowa S; Horikoshi N
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1613-8. PubMed ID: 8060136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
    Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
    Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.